Metastatic Breast Cancer
Clinical Trial - Miami
Have you taken Ibrance® or Kisqali®? The Amelia 1 clinical trial is OPEN in multiple MIAMI locations for patients with metastatic breast cancer. Please email the Miami study manager
or call 786 594-7856 (Ask about study SDX-0103)
Miami Cancer Institute, Baptist Hospital
**Open to Recruitment
8900 North Kendall Drive
Miami, FL
Contact: Xiaoou Pan, Clinical Research Coordinator
(786) 594-7856
Principal Investigator: Dr. Reshma L. Mahtani
Baptist Health Wellness and Medical Complex
**Open to Recruitment
1228 S Pine Island Rd.
Plantation, FL 33324
Contact: Xiaoou Pan, Clinical Research Coordinator
(786)-594-7856
Principal Investigator: Dr. Reshma L. Mahtani
Has Your Breast Cancer Spread Despite CDK 4/6 Treatment?
The Amelia 1 breast cancer clinical trial is testing patients with the PIK3CA gene mutation. Post-menopausal women with advanced or metastatic breast cancer who live in the Miami area are invited to apply to join the trial. Contact the clinical trial site closest to you for more details.
Amelia 1 is a clinical study developed by SynDevRx, Inc.
SynDevRX, Inc. Copyright 2022
Terms of Use
|
Privacy Policy
View our Clinical Trial Site Pages below for more details
